Methodology Pricing

Halozyme Therapeutics, Inc.

HALO

HealthcareBiotechnologyNASDAQ

$61.63

Market Cap: $7.27B

Valuation Financials Forecast Compare Historical Price Solvency Dividends Transactions People

Valuation Summary Discounted Cash Flow Trading Multiples PEG Fair Value Earnings Power Value Analyst Estimates Dividend Discount ModelSoon WACC

Similar Stocks to HALO

Coming soon

Dividend Discount Model

This section is coming soon.

SweetValueLab © 2026

Methodology Pricing About

Not financial advice. Data may be delayed.